» Articles » PMID: 30505657

Potassium 2-(1-hydroxypentyl)-benzoate Improves Depressive-like Behaviors in Rat Model

Overview
Publisher Elsevier
Specialty Pharmacology
Date 2018 Dec 4
PMID 30505657
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Potassium 2-(1-hydroxypentyl)-benzoate (PHPB) is a novel drug candidate for acute ischemic stroke. PHPB has been also shown to be beneficial for some neurodegenerative diseases. In this study, we demonstrated that PHPB improved depressive-like behaviors induced by chronic unpredictable mild stress (CUMS) in rats. Male SD rats were subjected to the stress for five weeks. PHPB (30 and 100 mg/kg) or fluoxetine (FLX 10 mg/kg, as positive control) was administered orally from the third week in CUMS procedure. The behavioral tests were applied and then the biochemical studies were carried out. PHPB or FLX treatment rescued the behavioral deficiency in CUMS-exposed rats. Meanwhile, PHPB normalized the enhanced level of serum corticosterone, improved hippocampal and serum BDNF levels, as well as p-CREB level in hippocampus. In addition, PHPB could reverse the reduced level of extracellular 5-HT and its metabolite 5-HIAA in prefrontal cortex (PFC) of depressed rats. In summary, our results showed that PHPB improved depression-like behaviors in CUMS-exposed rats. The mechanisms might relate to the reverse of neurotrophic disturbance in the brain, reducing excessive HPA axis response and facilitating the release of 5-HT.

Citing Articles

Genome-wide screen and multi-omics analysis reveal participate in the biosynthesis of safflower flavonoid glycosides.

Xian B, Zhou Y, Hu Y, Peng Y, Song X, Xi Z Hortic Res. 2024; 11(12):uhae261.

PMID: 39664694 PMC: 11632156. DOI: 10.1093/hr/uhae261.


Baicalin Ameliorates Depression-like Behaviors via Inhibiting Neuroinflammation and Apoptosis in Mice.

Yi Y, Liu G, Li Y, Wang C, Zhang B, Lou H Int J Mol Sci. 2024; 25(19).

PMID: 39408591 PMC: 11476789. DOI: 10.3390/ijms251910259.


Comparing the effect of fluoxetine, escitalopram, and sertraline, on the level of BDNF and depression in preclinical and clinical studies: a systematic review.

Talaee N, Azadvar S, Khodadadi S, Abbasi N, Asli-Pashaki Z, Mirabzadeh Y Eur J Clin Pharmacol. 2024; 80(7):983-1016.

PMID: 38558317 DOI: 10.1007/s00228-024-03680-y.


Cloning, expression and activity analysises of chalcone synthase genes in .

Tang X, Ren C, Hu J, Chen J, Wang J, Wang R Chin Herb Med. 2023; 15(2):291-297.

PMID: 37265765 PMC: 10230621. DOI: 10.1016/j.chmed.2022.12.005.


The Study of a Novel Paeoniflorin-Converting Enzyme from .

Ye Y, Pei H, Cao X, Liu X, Li Z, Wang B Molecules. 2023; 28(3).

PMID: 36770956 PMC: 9921665. DOI: 10.3390/molecules28031289.


References
1.
Campos A, Barros A, Albuquerque F, Leal L, Rao V . Acute effects of guarana (Paullinia cupana Mart.) on mouse behaviour in forced swimming and open field tests. Phytother Res. 2005; 19(5):441-3. DOI: 10.1002/ptr.1471. View

2.
Yang L, Li J, Xu S, Cai J, Lei H, Liu D . L-3-n-butylphthalide Promotes Neurogenesis and Neuroplasticity in Cerebral Ischemic Rats. CNS Neurosci Ther. 2015; 21(9):733-41. PMC: 6493029. DOI: 10.1111/cns.12438. View

3.
Maric N, Adzic M . Pharmacological modulation of HPA axis in depression - new avenues for potential therapeutic benefits. Psychiatr Danub. 2013; 25(3):299-305. View

4.
Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C . Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry. 2003; 54(1):70-5. DOI: 10.1016/s0006-3223(03)00181-1. View

5.
Nagayasu K, Kitaichi M, Nishitani N, Asaoka N, Shirakawa H, Nakagawa T . Chronic effects of antidepressants on serotonin release in rat raphe slice cultures: high potency of milnacipran in the augmentation of serotonin release. Int J Neuropsychopharmacol. 2013; 16(10):2295-306. DOI: 10.1017/S1461145713000771. View